Smaregi, Inc. AI Stock Analysis
Want to see JP:4431 full AI Analyst Report?
Smaregi, Inc. (4431) AI Stock Analysis
Smaregi, Inc.
(TSE/TYO:4431)
Smaregi earns a highly attractive score driven primarily by outstanding financial performance, characterized by rapid revenue growth, high profitability, and a pristine balance sheet. Strong technical momentum across all key moving averages and a reasonable valuation multiple for a high-growth software company further solidify its compelling profile.
Smaregi, Inc. (4431) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 59.42B
- Dividend Yield
- 0.75%
- Average Volume (3M)
- 95.77K
- Price to Earnings (P/E)
- 24.4
- Beta (1Y)
- 0.51
- Revenue Growth
- 20.70%
- EPS Growth
- 56.44%
- Country
- Japan
- Employees
- 477
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Application
Smaregi, Inc. Business Overview & Revenue Model
Company Description
Smaregi, Inc. plans, designs, develops, and provides web services. The company also offers Smaregi, a cloud type POS cash register system; Smaregi Techfirm (SES), provides training activities such as education and support at Sumaregi; PAYGATE, a cash...
Smaregi, Inc. Financial Statement Overview
Summary
Smaregi boasts a superb financial foundation with consistent top-line growth and expanding profit margins. The company maintains a virtually debt-free balance sheet and generates strong, growing free cash flow.
Income Statement
92Very PositiveBalance Sheet
96Very PositiveCash Flow
92Very Positive| Breakdown | TTM | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.94B | 13.35B | 11.07B | 8.39B | 5.91B | 4.30B |
| Gross Profit | 9.27B | 8.77B | 6.76B | 5.20B | 3.57B | 2.64B |
| EBITDA | 4.43B | 3.78B | 2.72B | 1.95B | 1.11B | 744.27M |
| Net Income | 2.54B | 2.23B | 1.64B | 1.21B | 887.60M | 444.98M |
Balance Sheet | ||||||
| Total Assets | 13.86B | 14.08B | 10.75B | 7.96B | 6.18B | 5.20B |
| Cash, Cash Equivalents and Short-Term Investments | 7.66B | 8.14B | 5.91B | 5.28B | 3.96B | 3.51B |
| Total Debt | 100.00M | 100.00M | 100.00M | 0 | 0 | 0 |
| Total Liabilities | 4.02B | 4.47B | 3.08B | 1.99B | 1.50B | 1.00B |
| Stockholders Equity | 9.83B | 9.61B | 7.67B | 5.97B | 4.68B | 4.20B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 2.74B | 1.79B | 1.35B | 806.71M | 116.59M |
| Operating Cash Flow | 0 | 3.12B | 2.47B | 1.71B | 986.44M | 222.99M |
| Investing Cash Flow | 0 | -606.77M | -1.92B | -393.08M | -310.73M | -84.51M |
| Financing Cash Flow | 0 | -288.35M | 82.22M | 8.84M | -447.94M | 17.21M |
Smaregi, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4431, the sentiment is Negative. The current price of 3215.00 is below the 20-day moving average (MA) of 3632.00, below the 50-day MA of 3584.80, and above the 200-day MA of 2856.53, indicating a neutral trend. The MACD of -80.57 indicates Positive momentum. The RSI at 34.58 is Neutral, neither overbought nor oversold. The STOCH value of 17.96 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4431.
Smaregi, Inc. Peers Comparison
Overall Rating
JP:443189Outperform
JP:437475Outperform
JP:376973Outperform
JP:362371Outperform
JP:449671Outperform
JP:363369Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 89Outperform | JPY 62.90B | 24.42 | ― | 0.75% | 20.70% | 56.44% | |
| 75Outperform | JPY 9.14B | 14.05 | ― | 1.19% | 14.08% | 28.55% | |
| 73Outperform | JPY 637.38B | 25.41 | 20.84% | 2.23% | 15.40% | 14.93% | |
| 71Outperform | JPY 6.67B | 11.97 | ― | 2.46% | 13.23% | 40.67% | |
| 71Outperform | JPY 5.66B | 19.35 | ― | 4.07% | 4.93% | 69.23% | |
| 69Neutral | JPY 12.24B | 8.34 | ― | 4.80% | -3.24% | 80.65% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4431 | Smaregi, Inc. | 3215.00 | 454.76 | 16.48% | |
| JP:3769 | GMO Payment Gateway | 8404.00 | -978.10 | -10.43% | |
| JP:3623 | Billing System Corporation | 1047.00 | 65.11 | 6.63% | |
| JP:3633 | GMO Pepabo, Inc. | 2314.00 | 209.24 | 9.94% | |
| JP:4374 | ROBOT PAYMENT INC. | 1179.00 | -227.81 | -16.19% | |
| JP:4496 | Commerce One Holdings, Inc. | 787.00 | 40.20 | 5.38% |
Smaregi, Inc. Corporate Events
Smaregi to Take Over Casio Subsidiary’s NetRegi Cloud POS Business
Smaregi has agreed to take over the NetRegi business from CXD NEXT, a Casio Computer subsidiary, via a simplified absorption-type company split effective December 1, 2026. The transfer will include assets, liabilities and contractual positions relate...
Smaregi posts sharp profit growth and maintains upbeat full-year outlook
Smaregi reported strong consolidated results for the three months ended July 31, 2026, with net sales rising 19.7% year on year to ¥3,608 million and operating profit surging 73.3% to ¥1,027 million. Ordinary profit reached ¥1,022 million and profit...
Smaregi Finalizes Terms for Director Stock Acquisition Rights
Smaregi, Inc. has finalized the terms for issuing paid stock acquisition rights as stock options to one of its directors, following a July 29, 2026 board resolution. The granted 3,000 stock acquisition rights will entitle the holder to acquire up to...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 29, 2026
